KOURTNEY MILENKOFF: Open Payments
NPI 1033743653 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,912 in 208 payments from 29 companies in 2025. Trend: 2023 $242 · 2024 $2,943 · 2025 $3,912
Food & beverage: $3,880Education: $32
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $700 |
| Amgen Inc. | 36 | $414 |
| Vanda Pharmaceuticals Inc. | 14 | $300 |
| Radius Health, Inc. | 11 | $284 |
| Otsuka America Pharmaceutical, Inc. | 11 | $260 |
| Novo Nordisk Inc | 11 | $217 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $180 |
| Almatica Pharma LLC | 12 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $152 |
| Abbott Laboratories | 1 | $140 |
Products named: OTEZLA, FANAPT, Tymlos, REXULTI, QULIPTA, Kerendia, LOREEV XR, VRAYLAR.
Industry payments across IL — which companies pay providers there.
